A comprehensive review on novel delivery approaches for exemestane
Author:
Funder
GLA University
Publisher
Elsevier BV
Subject
Pharmaceutical Science
Reference170 articles.
1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA;Bray;Cancer J. Clin.,2018
2. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA;Sung;Cancer J. Clin.,2021
3. Age Standardized (World) Incidence Rates, Breast, All Ages,2020
4. Nanoparticle-mediated targeted drug delivery for breast cancer treatment;Liyanage;Biochim. Biophys. Acta Rev. Canc,2019
5. Triple-negative breast cancer: clinical features and patterns of recurrence;Dent;Clin. Cancer Res.,2007
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Oral nano-formulations for endocrine therapy of endometrioid adenocarcinomas;Biomedicine & Pharmacotherapy;2024-10
2. A Short Appraisal of Magnetic Nanoparticles for Breast Cancer: In vitro and In vivo Research;Recent Patents on Nanotechnology;2024-06
3. Resveratrol-Exemestane Beneficial Regimen to Overcome the Complications over Existing Therapies for the Management of Breast Cancer;Current Molecular Medicine;2024-02
4. Incorporation of exemestane into ternary nanosponge system for enhanced anti-tumor potential in breast cancer;Pharmaceutical Development and Technology;2023-11-20
5. Co-delivery of exemestane and thymoquinone via nanostructured lipid carriers for efficient breast cancer therapy;Journal of Drug Delivery Science and Technology;2023-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3